277 related articles for article (PubMed ID: 2478482)
21. [Volume substitution in acute normovolemic hemodilution. 5% human albumin vs. 6% hydroxyethyl starch].
von Bormann B; Sticher J; Ratthey K; Idelberger R; Hempelmann G
Infusionstherapie; 1990 Jun; 17(3):142-6. PubMed ID: 1697284
[TBL] [Abstract][Full Text] [Related]
22. [Intra- and postoperative effect of various plasma substitutes on blood rheology and conjunctival oxygen partial pressure in microsurgical intervertebral disk operations].
Simon J; Jung F; Holbach T; Castor G; Jaksche H; Kiesewetter H
Infusionstherapie; 1989 Feb; 16(1):30-8. PubMed ID: 2469654
[TBL] [Abstract][Full Text] [Related]
23. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].
Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289
[TBL] [Abstract][Full Text] [Related]
24. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
25. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
26. [Hemorheologic therapy applications in coronary heart disease].
Leschke M; Motz W; Strauer BE
Wien Med Wochenschr; 1986; 136 Spec No():17-24. PubMed ID: 3825169
[TBL] [Abstract][Full Text] [Related]
27. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
28. [Conjunctival microcirculation and hemorheology in patients with venous occlusions of the retina].
Arend O; Wolf S; Schulte K; Jung F; Bertram B; Reim M
Fortschr Ophthalmol; 1991; 88(3):243-7. PubMed ID: 1889771
[TBL] [Abstract][Full Text] [Related]
29. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
30. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
[TBL] [Abstract][Full Text] [Related]
31. [Rheology and gravidic hypertension].
Heilmann L
Rev Fr Gynecol Obstet; 1991 Feb; 86(2 Pt 2):164-7. PubMed ID: 1722587
[TBL] [Abstract][Full Text] [Related]
32. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
Koltai K; Feher G; Kesmarky G; Keszthelyi Z; Czopf L; Toth K
Clin Hemorheol Microcirc; 2006; 35(4):517-25. PubMed ID: 17148851
[TBL] [Abstract][Full Text] [Related]
33. [Effect of a 10% and 6% hydroxyethyl starch solution (molecular weight 200,000/0.62) in comparison with a 10% dextran solution (molecular weight 40,000) on flow properties of blood and tissue oxygen pressure in patients with intermittent claudication].
Ehrly AM; Seebens H; Saeger-Lorenz K
Infusionstherapie; 1988 Oct; 15(5):181-7. PubMed ID: 2461906
[TBL] [Abstract][Full Text] [Related]
34. [Improvement of blood viscosity after infusion of low-molecular hydroxyethyl starch (Expafusin) in healthy subjects].
Ehrly AM; Landgraf H; Saeger-Lorenz K; Hasse S
Infusionsther Klin Ernahr; 1979 Dec; 6(6):331-6. PubMed ID: 94316
[TBL] [Abstract][Full Text] [Related]
35. Effect of hydroxyethyl starch (HAES) on degree and kinetics of erythrocyte aggregation studied with dielectric spectroscopy method.
Jaroszyński W; Keslinka E; Wujtewicz M; Suchorzewska J; Kwiatkowski B
Med Sci Monit; 2002 Jul; 8(7):BR272-8. PubMed ID: 12118190
[TBL] [Abstract][Full Text] [Related]
36. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
[TBL] [Abstract][Full Text] [Related]
38. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
39. [Effect of Expafusion (HES 40/0.5) on the corpuscular elements of blood and inhibitors of blood coagulation].
Köstering H; Giffhorn J; Negendank-Damenz B
Infusionsther Klin Ernahr; 1985 Dec; 12(6):304-7. PubMed ID: 2419250
[TBL] [Abstract][Full Text] [Related]
40. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
